History of early abuse as a predictor of treatment response in patients with fibromyalgia: A post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release

World Journal of Biological Psychiatry

Volumn 10, Issue 4 PART 2, 2009, Pages 435-441

  Pae, Chi Un ^a,b   Masand, Prakash S ^a   Marks, David M ^a   Krulewicz, Stan ^c   Han, Changsu ^a,d   Peindl, Kathleen ^a   Mannelli, Paolo ^a   Patkar, Ashwin A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b The Catholic University of Korea College of Medicine   (South Korea)

^c GLAXOSMITHKLINE   (United States)

^d Korea University   (South Korea)

Author keywords

Abuse; Fibromyalgia; Paroxetine CR; SSRI; Treatment

Indexed keywords

PAROXETINE; PLACEBO; ANTIDEPRESSANT AGENT;

ADULT; AGED; ANAMNESIS; ARTICLE; CLINICAL FEATURE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIBROMYALGIA; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; POST HOC ANALYSIS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEXUAL ABUSE; SHORT FORM 36; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ANALOG SCALE; CHILD; CHILD ABUSE; CHILD SEXUAL ABUSE; DELAYED RELEASE FORMULATION; DISABILITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; MIDDLE AGED; PAIN ASSESSMENT; PATIENT ATTITUDE; PSYCHOLOGICAL ASPECT;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CHILD; CHILD ABUSE; CHILD ABUSE, SEXUAL; DELAYED-ACTION PREPARATIONS; DISABILITY EVALUATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PAROXETINE; QUESTIONNAIRES; SICK ROLE; TREATMENT OUTCOME;

EID: 77449128793     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970902789155     Document Type: Article

References (37)

1. Alexander RW, Bradley LA, Alarcon GS, Triana-Alexander M, Aaron LA, Alberts KR, et al. 1998. Sexual and physical abuse in women with fibromyalgia: association with outpatient health care utilization and pain medication usage. Arthritis Care Res 11:102-115.
2. Arnold LM, Keck PE Jr, Welge JA. 2000. Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics 41:104-113.
3. Arnold LM, Hess EV, Hudson JI, Welge JA, Berno SE, Keck PE Jr. 2002. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med 112:191-197.
4. Ballenger JC, Wheadon DE, Steiner M, Bushnell W, Gergel IP. 1998. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. Am J Psychiatry 155:36-42
5. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. 1961. An inventory for measuring depression. Arch Gen Psychiatry 4:561-571.
6. Beck AT, Epstein N, Brown G, Steer RA. 1988. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56:893-897.
7. Boisset-Pioro MH, Esdaile JM, Fitzcharles MA. 1995. Sexual and physical abuse in women with fibromyalgia syndrome. Arthritis Rheum 38:235-241.
8. Burckhardt CS, Clark SR, Bennett RM. 1991. The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18:728-733.
9. Ciccone DS, Elliott DK, Chandler HK, Nayak S, Raphael KG. 2005. Sexual and physical abuse in women with fibromyalgia syndrome: a test of the trauma hypothesis. Clin J Pain 21:378-386.
10. Cohen S, Kamarck T, Mermelstein R. 1983. A global measure of perceived stress. J Health Soc Behav 24:385-396.
11. Gansky SA, Plesh O. 2007. Widespread pain and fibromyalgia in a biracial cohort of young women. J Rheumatol 34(4):810-817.
12. Goldberg RT, Pachas WN, Keith D. 1999. Relationship between traumatic events in childhood and chronic pain. Disabil Rehabil 21:23-30.
13. Golden RN, Nemeroff CB, McSorley P, Pitts CD, Dube EM. 2002. Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression. J Clin Psychiatry 63:577-584.
14. Goldenberg DL. 2008. Multidisciplinary modalities in the treatment of fibromyalgia. J Clin Psychiatry 69(Suppl 2):30-34.
15. Goldenberg DL, Burckhardt C, Crofford L. 2004. Management of fibromyalgia syndrome. J Am Med Assoc 292:2388-2395.
16. Harvey AG, Bryant RA, Tarrier N. 2003. Cognitive behaviour therapy for posttraumatic stress disorder. Clin Psychol Rev 23:501-522. (Pubitemid 36506801)
17. Imbierowicz K, Egle UT. 2003. Childhood adversities in patients with fibromyalgia and somatoform pain disorder. Eur J Pain 7:113-119.
18. King SJ, Wessel J, Bhambhani Y, Sholter D, Maksymowych W. 2002. Predictors of success of intervention programs for persons with fibromyalgia. J Rheumatol 29:1034-1040.
19. Kooiman CG, Ouwehand AW, ter Kuile MM. 2002. The Sexual and Physical Abuse Questionnaire (SPAQ). A screening instrument for adults to assess past and current experiences of abuse. Child Abuse Negl 26:939-953.
20. Leserman J. 2005. Sexual abuse history: prevalence, health effects, mediators, and psychological treatment. Psychosom Med 67:906-915.
21. Leserman J, Drossman DA, Li Z. 1995. The reliability and validity of a sexual and physical abuse history questionnaire in female patients with gastrointestinal disorders. Behav Med 21:141-150.
22. Marshall RD, Beebe KL, Oldham M, Zaninelli R. 2001. Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry 158: 1982-1988.
23. McBeth J, Macfarlane GJ, Benjamin S, Morris S, Silman AJ. 1999. The association between tender points, psychological distress, and adverse childhood experiences: a community-based study. Arthritis Rheum 42:1397-1404.
24. Meltzer-Brody S, Leserman J, Zolnoun D, Steege J, Green E, Teich A. 2007. Trauma and posttraumatic stress disorder in women with chronic pelvic pain. Obstet Gynecol 109:902-908.
25. Nemeroff CB, Heim CM, Thase ME, Klein DN, Rush AJ, Schatzberg AF, et al. 2003. Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Natl Acad Sci USA 100:14293-21426
26. O'Malley PG, Balden E, Tomkins G, Santoro J, Kroenke K, Jackson JL. 2000. Treatment of fibromyalgia with antidepressants: a meta-analysis. J Gen Intern Med 15:659-666.
27. Patkar AA, Masand PS, Krulewicz S, Mannelli P, Peindl K, Beebe KL, et al. 2007. A randomized, controlled, trial of controlled release paroxetine in fibromyalgia. Am J Med 120:448-454
28. Pollack MH, Zaninelli R, Goddard A, McCafferty JP, Bellew KM, Burnham DB, et al. 2001. Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry 62:350-357. (Pubitemid 32545557)
29. Sheehan D. 1983. The anxiety disease. New York: Scribner and Sons.
30. Stansfeld SA, Roberts R, Foot SP. 1997. Assessing the validity of the SF-36 General Health Survey. Qual Life Res 6:217-224.
31. Taylor ML, Trotter DR, Csuka ME. 1995. The prevalence of sexual abuse in women with fibromyalgia. Arthritis Rheum 38:229-234.
32. Turk DC, Okifuji A, Sinclair JD, Starz TW. 1998. Differential responses by psychosocial subgroups of fibromyalgia syndrome patients to an interdisciplinary treatment. Arthritis Care Res 11:397-404
33. Van Houdenhove B, Neerinckx E, Lysens R, Vertommen H, Van Houdenhove L, Onghena P, et al. 2001. Victimization in chronic fatigue syndrome and fibromyalgia in tertiary care: a controlled study on prevalence and characteristics. Psychoso-matics 42:21-28.
34. Walen HR, Cronan PA, Bigatti SM. 2001. Factors associated with healthcare costs in women with fibromyalgia. Am J Manag Care 7 Spec No:SP39-7.
35. Walker EA, Keegan D, Gardner G, Sullivan M, Bernstein D, Katon WJ. 1997. Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: II. Sexual, physical, and emotional abuse and neglect. Psychosom Med 59:572-577.
36. Weissbecker I, Floyd A, Dedert E, Salmon P, Sephton S. 2006. Childhood trauma and diurnal cortisol disruption in fibromyalgia syndrome. Psychoneuroendocrinology. 31:312-324.
37. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. 1990. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160-172.